Results 81 to 90 of about 5,814 (145)

Molecular Targeting of John Cunningham Virus ‎‎(JCV) Among Colorectal Tumors Patients in ‎Central Iraq

open access: yesJOURNAL of UNIVERSITY of BABYLON for Pure and Applied Sciences, 2017
In order to prove the implication of John Cunningham virus in colorectal cancer of Iraqi patients. Sixty eight (68) formalin-fixed, paraffin embedded colorectal tissues were obtained in this study ;42 biopsies from colorectal carcinoma (CRC) and (16) from benign colorectal tumors as well as (10) apparently normal colorectal autopsies control group. The
Abdullah, Zahraa ‎ Ali   +1 more
openaire   +1 more source

Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis. [PDF]

open access: yesJ Neurol Neurosurg Psychiatry
Gelissen LMY   +30 more
europepmc   +1 more source

Anti-John Cunningham virus antibody index levels in multiple sclerosis patients treated with rituximab, fingolimod, and dimethyl fumarate. [PDF]

open access: yesSurg Neurol Int, 2019
Farley S   +7 more
europepmc   +1 more source

The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study. [PDF]

open access: yesOpen Forum Infect Dis, 2019
Kartau M   +7 more
europepmc   +1 more source

Iron limitation differentially affects viral replication in key marine microbes. [PDF]

open access: yesProc Natl Acad Sci U S A
Yung CCM   +6 more
europepmc   +1 more source

Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab. [PDF]

open access: yesBMJ Neurol Open
Høgestøl EA   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy